Ipca Laboratories Ltd. shows moderate growth and profitability compared to its peers in the Pharmaceuticals & Drugs sector. The company holds a relatively high PE ratio, indicating potential overvaluation, while other peers demonstrate stronger profitability metrics and lower debt levels, suggesting a broader concern in the sector.

• • Ipca Laboratories Ltd. has a high PE ratio compared to peers, suggesting potential overvaluation.
• • Strongest performing peers exhibit better profitability and lower debt levels.
• • Financially weak companies are present with high debt and low margins.